Glycosylated albumin (GA) stands as an alternative glycemic marker when glycosylated hemoglobin measurements exhibit abnormal values owing to the various complications affecting the life span of erythrocytes ([@B1]). However, GA is affected in patients with albumin metabolism disorders such as nephrotic syndrome, liver cirrhosis, and thyroid disorders ([@B2]). Moreover, there are several reports on the renal handling of GA in diabetic nephropathy ([@B3]--[@B5]). The stage of diabetic nephropathy may affect the GA/A1C ratio. In this study, we examined the effect of the urinary albumin-to-creatinine ratio (UACR) on GA/A1C in type 2 diabetic patients with normoalbuminuria or microalbuminuria.

This was a cross-sectional study. A total group of 835 patients with type 2 diabetes was divided into four groups according to their UACR, as follows: the low-normoalbuminuria group consisted of 261 patients with \<15 mg/g creatinine; the high-normoalbuminuria group consisted of 143 patients with 15--29 mg/g creatinine; the low-microalbuminuria group consisted of 343 patients with 30--149 mg/g creatinine; and the high-microalbuminuria group consisted of 88 patients with 150--299 mg/g creatinine. The GA/A1C ratio and the correlation between GA and A1C were compared among the four groups.

[Table 1](#T1){ref-type="table"} shows the clinical characteristics of those patients categorized into the four groups according to the UACR. The GA/A1C ratio of low-normoalbuminuria patients (2.8 ± 0.4) was significantly lower than those of other groups (high-normoalbuminuria group 2.9 ± 0.4; low-microalbuminuria group 2.9 ± 0.4; high-microalbuminuria group 3.0 ± 0.3). A positive association between GA and A1C was found in each UACR group (low-normoalbuminuria group *r* = 0.696, *P* \< 0.001; high-normoalbuminuria group *r* = 0.658, *P* \< 0.001; low-microalbuminuria group *r* = 0.794, *P* \< 0.001; high-microalbuminuria group *r* = 0.916, *P* \< 0.001). The correlation coefficient between GA and A1C was significantly higher in high-microalbuminuria group than in the other groups (low-normoalbuminuria group *P* \< 0.001; high-normoalbuminuria group *P* \< 0.001; low-microalbuminuria group *P* \< 0.001).

Ghiggeri et al. ([@B3]) classified type 1 diabetic patients on the basis of the urinary albumin excretion rates of 15 and 150 mg/day, whereas Cha et al. ([@B4]) classified type 2 diabetic patients with normoalbuminuria into two subgroups of high and low albumin excretion. They demonstrated that the renal selectivity for GA, which was calculated from the ratio of the urinary to serum levels of GA, was inversely correlated with albumin clearance ([@B3]) or UACR ([@B4]). On the basis of these findings, we divided patients with normoalbuminuria or microalbuminuria into four groups of UACR: \<15, 15--29, 30--149, and 150--299 mg/g creatinine. We found that the coefficient correlation between GA and A1C as well as the GA/A1C ratio were higher in high-microalbuminuria patients than in low-normoalbuminuria patients. In those patients with a UACR \<15 mg/g creatinine, the urinary excretion rate of GA appears to be high and the GA/A1C ratio may be low. In those patients with an UACR \>150 mg/g creatinine, the urinary excretion rate of GA appears to be low and the GA/A1C ratio may be high. The GA/A1C ratio and the correlation coefficient between GA and A1C appear to vary according to the UACR. To make accurate conversions between GA and A1C values, the UACR should be taken into account.
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